Definitive Contract 75F40118C10189
Award Date
9/18/18
Potential Completion Date
9/25/19
Potential Value
$107K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20005, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the American Society of Nephrology Inc., a non-profit organization, with a potential value of $499,077.00. The contract is for building capacity to incorporate patient preferences into the development of innovative alternatives to renal replacement therapy. The contract does not have a set-aside designation. Based on the information provided, the American Society of Nephrology...
This is a $2,584,808.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the American Society of Nephrology, Inc. (ASN), a non-profit organization. The contract is for promoting infection prevention in dialysis settings. There is no set-aside designation. ASN has experience providing dialysis infection prevention services, research, and educational materials to federal agencies including the CDC and FDA through past prime contracts and...
American Society of Nephrology, Inc., a non-profit organization, was awarded a firm fixed price contract valued at $488,427.56 by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract promotes infection prevention in dialysis through July 2022, with a period of performance from July 2019 through completion. No set-aside designation was used for this award. The prime contractor will provide dialysis infection prevention services and conduct...
This is a $469,455.68 firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to the American Society of Nephrology, Inc., a non-profit organization. The contract is for dialysis infection prevention services in Fiscal Year 2020, with a period of performance through September 20, 2023. The contract has no set-aside designation. The contractor will be responsible for conducting a needs assessment evaluation of home dialysis to identify barriers and facilitators...
This is a $727,115.00 firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Research Triangle Institute (RTI) International, a non-profit research organization. The contract is for the evaluation of the Kidney Innovation Accelerator (KidneyX) program, which is a public-private partnership between HHS and the American Society of Nephrology to accelerate the development of innovative therapies...
This federal contract award, valued at $134,100.00, was issued by the Defense Health Agency (DHA) to the National Kidney Registry, a nonprofit organization that aims to increase the quality, speed, and number of living donor kidney transplants. The contract is a firm fixed price purchase order with no set-aside designation. The contract provides the DHA with products and services associated with organ transplants, including donor evaluation fees, donor nephrectomy procedures, and remote organ...
This is a $3,376,000.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to The Critical Path Institute (C-Path), a non-profit organization, for the development of drug development tools for Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD). The contract is not set aside for any specific business type. Under this contract, C-Path will collaborate with Wake Forest University Health Sciences (WFUHS), a subcontractor, to ingest, map, and curate ADTKD clinical...
<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract for nephrology consultant services to support a dialysis team. The contract was awarded to Nephrosci LLC, a minority-owned, woman-owned small business, on February 1, 2020, with a potential value of $156,480.00 and a completion date of January 31, 2021. The contract is for services to be performed in Atlanta, Georgia.</p>
This is a $2,101,382.00 delivery order contract awarded by the Department of Health and Human Services Centers for Medicare and Medicaid Services (CMS) to Health Services Advisory Group, Inc. (HSAG), a for-profit healthcare consulting firm. The contract is a re-compete of the End Stage Renal Disease (ESRD) Kidney Care Education and Resources (KCER) program, which coordinates care and quality initiatives for kidney failure patients. The contract has a period of performance through April 30,...
This is a $787,013 cost-reimbursement contract awarded by the Food and Drug Administration (FDA) to The Critical Path Institute (C-Path), a non-profit organization, for the "Clinical Evaluation and Qualification of Translational Kidney Safety Biomarkers." The contract, which does not have a set-aside designation, was awarded on September 8, 2016 and has a completion date of June 29, 2019. C-Path's work under this contract involves collaborating with industry, academia, and patient...